Internal Medicine Alert (Vol. 37, No. 19) - October 15, 2015 Specialty: Critical Care Format: Text Course #: 13519 Price: $42.00 Release date: 2015-10-05 Valid through: 2018-10-31 Publication: This activity appeared in Internal Medicine Alert , published on 2015-10-15. Course viewing requirements (opens in a new window) Instructions for Course Participation (opens in a new window) Legal disclaimer (opens in a new window) Release date: October 2015 Valid through: October 2018 Target Audience This CME activity is intended for the internist/family physician. Subjects Intensification of Oral Therapy for Type 2 Diabetes May Not Be Relevant to Primary Care Physicians Nutrition Therapy for Hypertension Using the Nitric Oxide Pathway Vitamin D and Diabetic Neuropathy Pharmacology Update: Evolocumab Injection (Repatha) Clinical Briefs: Reversing Anticoagulant Effect of Dabigatran; Likelihood of Occult Cancer Causing Unprovoked DVT; CAN Occurs Earlier in Type 2 Diabetes ECG Review: A 43-Year-Old Man with Atypical Chest Pain Objectives Describe new findings in differential diagnosis and treatment of various diseases Describe the advantages, disadvantages and controversies surrounding the latest advances in the diagnosis and treatment of disease Identify cost-effective treatment regimens Explain the advantages and disadvantages of new disease screening procedures. Credit Available Physicians Maximum of 2.0 AMA PRA Category 1 Credits 2.0 AOA Category 2-B credits 1.0 AAFP Credits Sponsor This activity is sponsored by AHC Media. Accreditation Statement AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Credit Designation Physicians AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits . Physicians should claim only the credit commensurate with the extent of their participation in the activity. The American Osteopathic Association has approved this continuing education activity for up to 2.0 AOA Category 2-B credits. Internal Medicine Alert has been reviewed and is acceptable for up to 1.0Prescribedcredit by the American Academy of Family Physicians. AAFP accreditation begins January 15, 2015. Term of approval is for one year from this date with the option of yearly renewal. Faculty Listing EDITOR Stephen A. Brunton , MD Adjunct Clinical Professor University of North Carolina, Chapel Hill ASSOCIATE EDITORS James Chan , PharmD, PhD Pharmacy Quality and Outcomes Manager, Kaiser Permanente, Oakland, CA William T. Elliott , MD, FACP Chair, Formulary Committee, Northern California Kaiser Permanente; Assistant Clinical Professor of Medicine, University of California, San Francisco Ken Grauer , MD Professor Emeritus in Family Medicine, College of Medicine, University of Florida Seema Gupta , MD, MSPH Primary Care Physician, Charleston, WV Harold L. Karpman , MD, FACC, FACP Clinical Professor of Medicine, UCLA School of Medicine Louis Kuritzky , MD Clinical Assistant Professor, University of Florida, Gainesville Martin S. Lipsky , MD Chancellor, South Jordan Campus, Roseman University of Health Sciences, South Jordan, UT Joseph E. Scherger , MD, MPH Vice President, Primary Care, Eisenhower Medical Center; Clinical Professor, Keck School of Medicine, University of Southern California Penny Tenzer , MD Associate Professor and Vice Chair, Department of Family Medicine and Community Health Chief of Service, Family Medicine, University of Miami Hospital University of Miami Miller School of Medicine Allan J. Wilke , MD, MA Professor and Chair Program Director Department of Family Medicine Western Michigan University School of Medicine, Kalamazoo PEER REVIEWER Gerald Roberts, MD Senior Attending Physician Long Island Jewish Medical Center NS/LIJ Health Care System New Hyde Park, NY Financial Disclosure Financial Disclosure: Internal Medicine Alerts editor, Stephen Brunton , MD, is a retained consultant for Abbott, AstraZeneca, Becton Dickinson, Boehringer Ingelheim, Janssen, Lilly, Novartis, Novo Nordisk, Sanofi, and Teva; he serves on the speakers bureau of AstraZeneca, Boehringer Ingelheim, Janssen, Lilly, Novo Nordisk, and Teva. Peer reviewer Gerald Roberts , MD; executive editor Leslie Coplin ; and associate managing editor Jonathan Springston report no financial relationships relevant to this field of study. Dr. Karpman reports no financial relationships relevant to this field of study. Dr. Kuritzky reports no financial relationships relevant to this field of study.
Ratings and Reviews
To review this course, please login.Login